20.51
1.28%
0.26
Handel nachbörslich:
20.51
Schlusskurs vom Vortag:
$20.25
Offen:
$20.22
24-Stunden-Volumen:
601.56K
Relative Volume:
1.64
Marktkapitalisierung:
$1.19B
Einnahmen:
$1.12B
Nettoeinkommen (Verlust:
$55.30M
KGV:
21.59
EPS:
0.95
Netto-Cashflow:
$-30.30M
1W Leistung:
-0.92%
1M Leistung:
+0.39%
6M Leistung:
+69.93%
1J Leistung:
+12.14%
Embecta Corp Stock (EMBC) Company Profile
Firmenname
Embecta Corp
Sektor
Telefon
(862) 401-0000
Adresse
1209 ORANGE STREET, WILMINGTON
Vergleichen Sie EMBC mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
EMBC
Embecta Corp
|
20.51 | 1.19B | 1.12B | 55.30M | -30.30M | 0.95 |
ISRG
Intuitive Surgical Inc
|
535.29 | 190.66B | 7.87B | 2.24B | 586.00M | 6.22 |
BDX
Becton Dickinson Co
|
228.46 | 66.26B | 20.18B | 1.71B | 3.07B | 5.94 |
ALC
Alcon Inc
|
84.06 | 41.58B | 9.76B | 1.16B | 665.00M | 2.34 |
RMD
Resmed Inc
|
231.67 | 34.01B | 4.81B | 1.11B | 1.35B | 7.55 |
WST
West Pharmaceutical Services Inc
|
335.56 | 24.30B | 2.88B | 499.60M | 321.60M | 6.74 |
Embecta Corp Stock (EMBC) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-12-02 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
2024-11-27 | Hochstufung | BTIG Research | Neutral → Buy |
2023-10-20 | Eingeleitet | Wolfe Research | Peer Perform |
2023-01-06 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
2022-09-08 | Eingeleitet | BTIG Research | Neutral |
2022-08-01 | Eingeleitet | Morgan Stanley | Equal-Weight |
2022-06-21 | Eingeleitet | BofA Securities | Underperform |
Alle ansehen
Embecta Corp Aktie (EMBC) Neueste Nachrichten
BDX: 3 Healthcare Innovators Advancing Medical Technology - StockNews.com
Argentina Diabetes Devices Market to Worth Over US$ 1,031.89 Million by 2033 | Astute Analytica - GlobeNewswire Inc.
Embecta Corp. (NASDAQ:EMBC) Stock Position Raised by Barclays PLC - MarketBeat
Geode Capital Management LLC Purchases 45,228 Shares of Embecta Corp. (NASDAQ:EMBC) - MarketBeat
Zacks.com featured highlights include The Gap, Embecta, Blue Bird and ZIM Integrated Shipping Services - Yahoo Finance
Embecta Corp. (NASDAQ:EMBC) Shares Purchased by Jane Street Group LLC - MarketBeat
Embecta to Participate at the 43rd Annual J.P. Morgan Healthcare Conference - Marketscreener.com
embecta to Participate at the 43rd Annual J.P. Morgan Healthcare Conference - Eagle-Tribune
Embecta To Participate At The 43rd Annual J.P. Morgan Healthcare Conference - Barchart
Embecta to Present at J.P. Morgan Healthcare Conference 2025: Key Updates Expected - StockTitan
Embecta Corp. Announces Quarterly Cash Dividend, Payable December 18, 2024 - Marketscreener.com
Embecta Corp. (NASDAQ:EMBC) Sees Significant Drop in Short Interest - MarketBeat
Garden State Investment Advisory Services LLC Buys New Position in Embecta Corp. (NASDAQ:EMBC) - MarketBeat
Embecta (EMBC) Passes Through 3% Yield Mark - Nasdaq
Embecta Cutting 100+ Jobs In Andover - Andover News
Meros Investment Management LP Makes New $2.68 Million Investment in Embecta Corp. (NASDAQ:EMBC) - MarketBeat
Learn to Evaluate (EMBC) using the Charts - Stock Traders Daily
Here Is Why Bargain Hunters Would Love Fast-paced Mover Embecta Corp. (EMBC) - MSN
Charles Schwab Investment Management Inc. Has $13.58 Million Stock Position in Embecta Corp. (NASDAQ:EMBC) - MarketBeat
Embecta Corp. (NASDAQ:EMBC) Shares Sold by Jacobs Levy Equity Management Inc. - MarketBeat
Embecta to cut 125 jobs after ending insulin patch pump - MedTech Dive
Embecta to lay off 118 in Massachusetts following patch pump program discontinuation - Drug Delivery Business News
Ex-Dividend Reminder: TEGNA, Embecta and Popular - Nasdaq
Diabetes company to lay off more than 100 employees in Andover - The Business Journals
New Initiatives Expected To Make Embecta More Profitable (NASDAQ:EMBC) - Seeking Alpha
Morgan Stanley bullish on medtech in 2025, upgrades 5 stocks - MSN
Embecta Corp. appoints new Chief Accounting Officer - Investing.com India
Embecta Corp. appoints new Chief Accounting Officer By Investing.com - Investing.com South Africa
Embecta Corp Appoints Anthony Roth as VP and CAO - TipRanks
Embecta Corp. Announces Executive Changes - Marketscreener.com
Morgan Stanley bullish on medtech in 2025, upgrades 5 stocks (NASDAQ:ISRG) - Seeking Alpha
Embecta Corp (EMBC) Trading Down 3.55% on Dec 2 - GuruFocus.com
New Strong Buy Stocks for December 2nd - MSN
Embecta raised to buy at BTIG after Q4 update - MSN
Embecta upgraded to Equal Weight from Underweight at Morgan Stanley - TipRanks
Embecta to discontinue insulin patch pump program, initiates restructuring plan - MSN
Embecta sees FY25 adjusted EPS $2.70-$2.90, consensus $2.27 - MSN
Embecta (NASDAQ:EMBC) Shares Gap DownShould You Sell? - MarketBeat
Isthmus Partners LLC Has $1.56 Million Stock Position in Embecta Corp. (NASDAQ:EMBC) - MarketBeat
Is It Time To Consider Buying Embecta Corp. (NASDAQ:EMBC)? - Yahoo Finance
Embecta (NASDAQ:EMBC) Is Due To Pay A Dividend Of $0.15 - Simply Wall St
Algert Global LLC Has $1.48 Million Stake in Embecta Corp. (NASDAQ:EMBC) - MarketBeat
BTIG Upgrades Embecta (EMBC) - MSN
Embecta reports Q4 adjusted EPS 45c, consensus 36c - MSN
Embecta stock outlook brightens with Buy rating on strategic focus and global footprint - Investing.com Canada
Embecta Corp. Reports Earnings Results for the Full Year Ended September 30, 2024 - Marketscreener.com
This Dick's Sporting Goods Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday - Benzinga
Embecta stock raised to buy at BTIG (EMBC:NASDAQ) - Seeking Alpha
Embecta stock outlook brightens with Buy rating on strategic focus and global footprint By Investing.com - Investing.com South Africa
Finanzdaten der Embecta Corp-Aktie (EMBC)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):